Bausch Health Co. Inc. (BHC) Q3 Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips briefly below $100 on Saudi exports, hopes of US-Iran diplomacy
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
Bausch Health Companies Inc. Announces Third-Quarter 2021 Results
November 2, 2021 6:59 AM EDTLAVAL, Quebec, Nov. 2, 2021 /PRNewswire/ --
Third-Quarter 2021 Financial Results Revenues of $2.111 Billion GAAP Net Income of $188 Million Adjusted EBITDA (non-GAAP)1Â of $885 Million GAAP Cash Generated from Operations of $564 MillionExpects to Launch Solta Medical IPO2 in December 2021 or January 2022 and Bausch + Lomb IPO Approximately 30 Days Following Solta Medical IPO3 Reaffirmed 2021 Full-Year Revenue and Adjusted EBITDA (non-GAAP) Guidance RangesBausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch... More
